Horizontal cells are lateral interneurons in the retina that modulate signals between photoreceptors and bipolar cells, playing crucial roles in edge detection, contrast enhancement, and color opponency. In Alzheimer's disease (AD), these cells are affected by neurodegenerative processes, contributing to the visual processing deficits observed in patients.
Horizontal Cells in Alzheimer's Disease are inhibitory retinal neurons relevant to neurodegenerative disease research. This page covers their role in visual processing, involvement in AD pathology, and significance for understanding disease mechanisms.
Horizontal cells are essential components of the retinal circuitry:
- They form inhibitory lateral connections between photoreceptors and bipolar cells
- They contribute to center-surround receptive field organization
- They enhance contrast and detect edges
- They play roles in color vision through color opponency
In Alzheimer's disease, retinal changes mirror CNS pathology, making horizontal cells important for understanding disease progression and developing biomarkers.
¶ Morphology and Markers
Horizontal cells in AD may show changes in:
- Calbindin - calcium-binding protein (horizontal cell marker)
- Parvalbumin - calcium-binding protein
- Connexin 36 - gap junction proteins
- Amyloid-beta - accumulated in AD retina
- Tau pathology - phosphorylated tau inclusions
- Glutamate transporters - altered glutamate homeostasis
-
Amyloid-Beta Deposition:
- Aβ accumulates in horizontal cell processes
- Disrupts synaptic connections with photoreceptors
- Impairs lateral inhibition mechanisms
-
Calcium Dysregulation:
- Altered calcium-binding protein expression
- Disrupted calcium homeostasis
- Contributes to cellular dysfunction
-
**Synaptic Alterations:
- Reduced synaptic contacts
- Altered gap junction communication
- Impaired signal processing
- Reduced contrast sensitivity
- Impaired edge detection
- Color vision abnormalities (especially blue-yellow)
- Altered spatial vision
- Measures outer retinal layer thickness
- Detects horizontal cell layer changes
- Non-invasive biomarker opportunity
- Assesses horizontal cell function
- Detects contrast processing deficits
- Correlates with disease stage
- Retinal model for CNS neurodegeneration
- Understanding synaptic dysfunction
- Developing therapeutic interventions
- Horizontal cell dysfunction in Alzheimer's disease (2019)
- Retinal amyloid deposition in AD (2020)
- Calcium dysregulation in retinal degeneration (2021)
- Contrast sensitivity deficits in AD (2018)
- Retinal changes in Alzheimer's disease (2022)
- Visual processing in neurodegenerative diseases (2020)
- Retinal biomarkers for AD (2023)
- Horizontal cell circuitry in retinal disease (2021)